Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients
Published Online: Thursday, January 16, 2014
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.
Vitamin D supplements can reduce the severity and duration of chronic obstructive pulmonary disease flare-ups by more than 40%.
The flavorings used to improve the taste of electronic cigarettes may pose their own respiratory health hazards.
In a study of patients with comorbid COPD and metabolic syndrome, elevated triglyceride levels were associated with increased mortality rates.